Request for Public Comment: 60 Day Notice for Extension of Fast Track Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery: Indian Health Service Customer Service Satisfaction and Similar Surveys, 104550-104552 [2024-30541]
Download as PDF
<![CDATA[
104550
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
The reorganization will improve
FDA’s ability to carry out its public
health mission by realigning and
dedicating resources within the
organization to modernize clinical trials.
The clinical trial innovation work tracks
will place DCI at the forefront to
robustly meet policy development,
implementation, and analysis needs in
areas such as Artificial Intelligence (AI),
Digital Health Technologies (DHTs),
Real-World Evidence (RWE), and other
rapidly advancing sectors in the
dynamic clinical trial ecosystem.
The CDER, OMP, Office of Medical
Policy Initiatives retitled the Division of
Clinical Trial Quality to the Division of
Clinical Innovations.
The reorganization will enhance the
office’s ability to attract and retain a
diverse workforce representative of our
nation and bring like scientists and
policy experts together from across the
organization, thereby facilitating
collaboration and efficient use of shared
resources while advancing key
innovations in drug development. By
developing responsive policies, the
Division of Clinical Innovations will
modernize the policy environment to
ensure that CDER is providing the
needed regulatory perspective to guide
the appropriate use of such tools and
technologies.
The FDA’s CDER, OMP has been
restructured as follows:
DCDH ORGANIZATION. The CDER
OMP (DCDH) is headed by the Director,
OMP and includes the following:
Office of Medical Policy (DCDH)
Office of Prescription Drug Promotion
(DCDHA)
Division of Advertising and Promotion
Review II (DCDHAA)
Division of Advertising and Promotion
Review I (DCDHAB)
Division of Promotion Policy, Research
and Operations (DCDHAC)
Office of Medical Policy Initiatives
(DCDHB)
Division of Medical Policy Development
(DCDHBA)
Division of Medical Policy Programs
(DCDHBB)
Division of Clinical Innovations
(DCDHBC)
khammond on DSK9W7S144PROD with NOTICES
II. Delegations of Authority
Pending further delegation, directives,
or orders by the Commissioner of Food
and Drugs, all delegations and
redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegations, provided
they are consistent with this
reorganization.
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
III. Electronic Access
This reorganization is reflected in
FDA’s Staff Manual Guide (SMG).
Persons interested in seeing the
complete Staff Manual Guide can find it
on FDA’s website at: https://
www.fda.gov/AboutFDA/
ReportsManualsForms/
StaffManualGuides/default.htm.
Authority: 44 U.S.C. 3101.
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2024–30333 Filed 12–20–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Council on Blood Stem Cell
Transplantation
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
Advisory Council on Blood Stem Cell
Transplantation (ACBSCT or Council)
has scheduled a public meeting.
Information about ACBSCT and the
agenda for the meeting can be found on
the ACBSCT website at https://
bloodstemcell.hrsa.gov/about/advisorycouncil.
DATES: Thursday, January 23, 2025, 3:00
p.m.–5:00 p.m. Eastern Standard Time.
ADDRESSES: This meeting will be held
virtually by webinar. A link to register
and join the meeting will be posted at
least 10 days prior to the meeting at
https://bloodstemcell.hrsa.gov/about/
advisory-council.
FOR FURTHER INFORMATION CONTACT:
Shelley Tims Grant, Designated Federal
Official, Division of Transplantation,
Health Systems Bureau, HRSA, 5600
Fishers Lane, 8W–67, Rockville,
Maryland 20857; 301–443–8036; or
ACBSCTHRSA@hrsa.gov.
SUPPLEMENTARY INFORMATION: ACBST
provides advice and recommendations
to the Secretary of HHS (Secretary) on
policy, program development, and other
matters of significance concerning the
activities under the authority of 42
U.S.C. 274k (Section 379 of the Public
Health Service Act), Public Law 109–
129, as amended. The Council may
transmit its recommendations through
the Administrator of HRSA on matters
related to the activities of the C.W. Bill
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Young Cell Transplantation Program
and National Cord Blood Inventory.
The agenda for the January 23, 2025,
meeting is being finalized and may
include the following topics: graft
versus host disease and late effects,
strategies for selecting cord blood units
for transplantation, HHS’ approach for
reviewing the state of the science and
recommendations on the
appropriateness of the inclusion of adult
stem cells and birthing tissues as new
types of therapies in the C.W. Bill
Young Cell Transplantation Program,
and other areas to increase blood stem
cell donation and transplantation.
Agenda items are subject to change as
priorities dictate. Refer to ACBSCT’s
website for any updated information
concerning the meeting. Members of the
public will have the opportunity to
provide comments. Public participants
may submit written statements in
advance of the scheduled meetings; oral
comments will be honored in the order
they are requested and may be limited
as time allows. Requests to submit a
written statement or make oral
comments to ACBSCT should be sent to
Shelley Tims Grant, using the contact
information above at least 3 business
days prior to the meeting. Individuals
who plan to attend and need special
assistance or other reasonable
accommodations should notify ACBSCT
at the address and phone number listed
above at least 10 business days prior to
the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–30604 Filed 12–20–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day
Notice for Extension of Fast Track
Generic Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery: Indian Health Service
Customer Service Satisfaction and
Similar Surveys
Indian Health Service, HHS.
Notice and request for
comments. Request for extension of
approval.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the
general public to take this opportunity
to comment on the information
collection Office of Management and
Budget (OMB) Control Number 0917–
SUMMARY:
E:\FR\FM\23DEN1.SGM
23DEN1
khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
0036, ‘‘Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.’’ This notice
announces our intent to submit this
previously approved information
collection, which expires February 28,
2025, to the OMB for approval of an
extension and solicit comments on
specific aspects for the proposed
information collection.
DATES: Consideration will be given to all
comments received by February 21,
2025.
ADDRESSES: Submit comments to
Patricia Lawton by email at
Patricia.Lawton@ihs.gov.
Comments submitted in response to
this notice will be made available to the
public by publishing them in the 30-day
Federal Register Notice for this
information collection. For this reason,
please do not include information of a
confidential nature, such as sensitive
personal information or proprietary
information. If comments are submitted
via email, the email address will be
automatically captured and included as
part of the comment that is placed in the
public docket and made available on the
internet. Please note that responses to
this public comment request containing
any routine notice about the
confidentiality of the communication
will be treated as public comments that
may be made available to the public
notwithstanding the inclusion of the
routine notice.
A copy of the draft supporting
statement is available at
www.regulations.gov (see Docket ID
IHS_FRDOC_0001).
SUPPLEMENTARY INFORMATION: The IHS is
submitting the proposed information
collection to OMB for review, as
required by the Paperwork Reduction
Act of 1995, as amended, and its
implementing regulations. This notice is
soliciting comments from members of
the public and affected agencies as
required by 44 U.S.C. 3506(c)(2)(A) and
5 CFR 1320.8(d) concerning the
proposed collection of information to:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the Agency’s estimate of the
burden of the proposed collection of
information; (3) Enhance the quality,
utility, and clarity of the information to
be collected; and (4) Minimize the
burden of the collection of information
on those who are to respond; including
through the use of appropriate
automated collection techniques of
other forms of information technology,
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
e.g., permitting electronic submission of
responses.
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery: Indian Health
Service Customer Service Satisfaction
and Similar Surveys.
Type of Information Collection
Request: Three year extension approval
of this information collection.
OMB Control Number: 0917–0036.
Abstract: The proposed information
collection activity provides a means to
garner qualitative customer and
stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. Qualitative
feedback is information that provides
useful insights on perceptions and
opinions, but is not statistical surveys
that yield quantitative results that can
be generalized to the population of
study. This feedback will provide
insights into customer or stakeholder
perceptions, experiences and
expectations, provide an early warning
of issues with service, or focus attention
on areas where communication, training
or changes in operations might improve
delivery of products or services. These
collections will allow for ongoing,
collaborative and actionable
communications between the Agency
and its customers and stakeholders. It
will also allow feedback to contribute
directly to the improvement of program
management.
The solicitation of feedback will target
areas such as: timeliness,
appropriateness, accuracy of
information, courtesy, efficiency of
service delivery, and resolution of
issues with service delivery. Responses
will be assessed to plan and inform
efforts to improve or maintain the
quality of service offered to the public.
If this information is not collected, vital
feedback from customers and
stakeholders on the Agency’s services
will be unavailable.
The Agency will only submit a
collection for approval under this
generic clearance if it meets the
following conditions:
• Information gathered will be used
only internally for general service
improvement and program management
purposes and is not intended for release
outside of the Agency;
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions;
• Information gathered will yield
qualitative information; the collections
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study;
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
104551
• The collections are voluntary;
• The collections are low-burden for
respondents (based on considerations of
total burden hours, total number of
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the Federal
Government;
• The collections are noncontroversial and do not raise issues of
concern to other Federal agencies;
• Any collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future; and
• With the exception of information
needed to provide remuneration for
participants of focus groups and
cognitive laboratory studies, personally
identifiable information (PII) is
collected only to the extent necessary
and is not retained.
Feedback collected under this generic
clearance provides useful information,
but it does not yield data that can be
generalized to the overall population.
This type of generic clearance for
qualitative information will not be used
for quantitative information collections
that are designed to yield reliably
actionable results, such as monitoring
trends over time or documenting
program performance. Such data uses
require more rigorous designs that
address: the target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
As a general matter, information
collections will not result in any new
system of records containing privacy
information and will not ask questions
of a sensitive nature, such as sexual
behavior and attitudes, religious beliefs,
and other matters that are commonly
considered private.
Current Actions: Extension of
approval for a collection of information.
Type of Review: Extension.
Affected Public: Individuals and
households, businesses and
organizations, and Tribal governments.
Estimated Number of Respondents:
105,000.
E:\FR\FM\23DEN1.SGM
23DEN1
104552
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
Below are projected annual average
estimates for the next 3 years:
Average Expected Annual Number of
activities: 100.
Average number of Respondents per
Activity: 1050.
Annual responses: 105,000.
Frequency of Response: Once per
request.
Average minutes per response: 10.
Burden hours: 17,500.
There are no direct costs to
respondents to report.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
Comment Due Date: Your comments
regarding this information collection are
best assured of having full effect if
received within 60-days of the date of
this publication.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2024–30541 Filed 12–20–24; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
khammond on DSK9W7S144PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Role of tau in
non-neuronal dysfunction in Alzheimer’s
Disease (AD) and Related Disorders (RD).
Date: February 5, 2025.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Nesar Uddin Akanda,
M.D., Ph.D., Scientific Review Officer
National Institute of Aging, National Institute
of Health, 5601 Fishers Lane, Room 2E405,
Rockville, MD 20852, (301) 594–8984,
nesar.akanda@nih.gov.
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2024–30560 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Mechanisms
of the age-related changes in gait
biomechanics and the impact on the
increased metabolic cost of walking.
Date: February 20, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Nesar Uddin Akanda,
M.D., Ph.D., Scientific Review Officer,
National Institute of Aging, National Institute
of Health, 5601 Fishers Lane, Room 2E405,
Rockville, MD 20852, (301) 594–8984,
nesar.akanda@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30558 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Inequities in
Digital Health for Older Adults with
Cognitive Decline and ADRD.
Date: February 21, 2025.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Rajasri Roy, Ph.D., MPH,
Scientific Review Officer, National Institute
of Aging, National Institute of Health, 5601
Fishers Lane, Room 100, Rockville, MD
20852, (301) 496–9666, rajasri.roy@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30563 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Pages 104550-104552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30541]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day Notice for Extension of Fast
Track Generic Clearance for the Collection of Qualitative Feedback on
Agency Service Delivery: Indian Health Service Customer Service
Satisfaction and Similar Surveys
AGENCY: Indian Health Service, HHS.
ACTION: Notice and request for comments. Request for extension of
approval.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the general public to take this
opportunity to comment on the information collection Office of
Management and Budget (OMB) Control Number 0917-
[[Page 104551]]
0036, ``Generic Clearance for the Collection of Qualitative Feedback on
Agency Service Delivery.'' This notice announces our intent to submit
this previously approved information collection, which expires February
28, 2025, to the OMB for approval of an extension and solicit comments
on specific aspects for the proposed information collection.
DATES: Consideration will be given to all comments received by February
21, 2025.
ADDRESSES: Submit comments to Patricia Lawton by email at
[email protected].
Comments submitted in response to this notice will be made
available to the public by publishing them in the 30-day Federal
Register Notice for this information collection. For this reason,
please do not include information of a confidential nature, such as
sensitive personal information or proprietary information. If comments
are submitted via email, the email address will be automatically
captured and included as part of the comment that is placed in the
public docket and made available on the internet. Please note that
responses to this public comment request containing any routine notice
about the confidentiality of the communication will be treated as
public comments that may be made available to the public
notwithstanding the inclusion of the routine notice.
A copy of the draft supporting statement is available at
www.regulations.gov (see Docket ID IHS_FRDOC_0001).
SUPPLEMENTARY INFORMATION: The IHS is submitting the proposed
information collection to OMB for review, as required by the Paperwork
Reduction Act of 1995, as amended, and its implementing regulations.
This notice is soliciting comments from members of the public and
affected agencies as required by 44 U.S.C. 3506(c)(2)(A) and 5 CFR
1320.8(d) concerning the proposed collection of information to: (1)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the Agency, including
whether the information will have practical utility; (2) Evaluate the
accuracy of the Agency's estimate of the burden of the proposed
collection of information; (3) Enhance the quality, utility, and
clarity of the information to be collected; and (4) Minimize the burden
of the collection of information on those who are to respond; including
through the use of appropriate automated collection techniques of other
forms of information technology, e.g., permitting electronic submission
of responses.
Title: Generic Clearance for the Collection of Qualitative Feedback
on Agency Service Delivery: Indian Health Service Customer Service
Satisfaction and Similar Surveys.
Type of Information Collection Request: Three year extension
approval of this information collection.
OMB Control Number: 0917-0036.
Abstract: The proposed information collection activity provides a
means to garner qualitative customer and stakeholder feedback in an
efficient, timely manner, in accordance with the Administration's
commitment to improving service delivery. Qualitative feedback is
information that provides useful insights on perceptions and opinions,
but is not statistical surveys that yield quantitative results that can
be generalized to the population of study. This feedback will provide
insights into customer or stakeholder perceptions, experiences and
expectations, provide an early warning of issues with service, or focus
attention on areas where communication, training or changes in
operations might improve delivery of products or services. These
collections will allow for ongoing, collaborative and actionable
communications between the Agency and its customers and stakeholders.
It will also allow feedback to contribute directly to the improvement
of program management.
The solicitation of feedback will target areas such as: timeliness,
appropriateness, accuracy of information, courtesy, efficiency of
service delivery, and resolution of issues with service delivery.
Responses will be assessed to plan and inform efforts to improve or
maintain the quality of service offered to the public. If this
information is not collected, vital feedback from customers and
stakeholders on the Agency's services will be unavailable.
The Agency will only submit a collection for approval under this
generic clearance if it meets the following conditions:
Information gathered will be used only internally for
general service improvement and program management purposes and is not
intended for release outside of the Agency;
Information gathered will not be used for the purpose of
substantially informing influential policy decisions;
Information gathered will yield qualitative information;
the collections will not be designed or expected to yield statistically
reliable results or used as though the results are generalizable to the
population of study;
The collections are voluntary;
The collections are low-burden for respondents (based on
considerations of total burden hours, total number of respondents, or
burden-hours per respondent) and are low-cost for both the respondents
and the Federal Government;
The collections are non-controversial and do not raise
issues of concern to other Federal agencies;
Any collection is targeted to the solicitation of opinions
from respondents who have experience with the program or may have
experience with the program in the near future; and
With the exception of information needed to provide
remuneration for participants of focus groups and cognitive laboratory
studies, personally identifiable information (PII) is collected only to
the extent necessary and is not retained.
Feedback collected under this generic clearance provides useful
information, but it does not yield data that can be generalized to the
overall population. This type of generic clearance for qualitative
information will not be used for quantitative information collections
that are designed to yield reliably actionable results, such as
monitoring trends over time or documenting program performance. Such
data uses require more rigorous designs that address: the target
population to which generalizations will be made, the sampling frame,
the sample design (including stratification and clustering), the
precision requirements or power calculations that justify the proposed
sample size, the expected response rate, methods for assessing
potential non-response bias, the protocols for data collection, and any
testing procedures that were or will be undertaken prior to fielding
the study. Depending on the degree of influence the results are likely
to have, such collections may still be eligible for submission for
other generic mechanisms that are designed to yield quantitative
results.
As a general matter, information collections will not result in any
new system of records containing privacy information and will not ask
questions of a sensitive nature, such as sexual behavior and attitudes,
religious beliefs, and other matters that are commonly considered
private.
Current Actions: Extension of approval for a collection of
information.
Type of Review: Extension.
Affected Public: Individuals and households, businesses and
organizations, and Tribal governments.
Estimated Number of Respondents: 105,000.
[[Page 104552]]
Below are projected annual average estimates for the next 3 years:
Average Expected Annual Number of activities: 100.
Average number of Respondents per Activity: 1050.
Annual responses: 105,000.
Frequency of Response: Once per request.
Average minutes per response: 10.
Burden hours: 17,500.
There are no direct costs to respondents to report.
An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number.
Comment Due Date: Your comments regarding this information
collection are best assured of having full effect if received within
60-days of the date of this publication.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2024-30541 Filed 12-20-24; 8:45 am]
BILLING CODE 4165-16-P
